Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cybin Inc (NY: CYBN ) 0.2645 -0.0004 (-0.15%) Official Closing Price Updated: 5:00 PM EDT, Jul 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cybin Inc < Previous 1 2 3 4 5 6 7 8 9 ... 37 38 Next > Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns July 03, 2024 Psychedelics could be a game-changer in treating mental health issues, creating substantial opportunities for top psychedelic stocks. Via InvestorPlace 3 Psychedelic Stocks to Buy on the Dip: Summer 2024 July 02, 2024 These are three of the best psychedelic stocks to buy on the dip for potentially lucrative future growth and returns. Via InvestorPlace CYBN Stock Earnings: Cybin Beats EPS for Q4 2023 June 26, 2024 CYBN stock results show that Cybin beat analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace Biopharma Co. Cybin Reports $78M Loss Amid Accelerating Expansion In Psychedelic Therapies, Drug Development June 26, 2024 Explore Cybin Inc.'s FY 2024 results: $78M loss and strides in psychedelic therapy for mental health. Read now! Via Benzinga Cybin Reports Fiscal Year 2024 Financial Results and Recent Business Highlights June 26, 2024 From Cybin Inc. Via Business Wire InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Releases FY Financial Report, Business Update June 26, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Product Safety InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO Featured Presenter at Upcoming H.C. Wainwright Neuro Perspectives Virtual Conference June 20, 2024 Via Investor Brand Network Cybin to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference June 19, 2024 From Cybin Inc. Via Business Wire Latest Executive Cannabis Changes You Should Know About: Curaleaf, Planet 13 Elect Directors And More June 18, 2024 As the premier gathering of top entrepreneurs and investors is taking place this Monday in New Jersey, let's scroll through the latest leadership changes in the cannabis and psychedelics... Via Benzinga Topics Cannabis Exposures Cannabis InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Announces Strategic Appointment of Dr. Atul Mahableshwarkar June 11, 2024 Via Investor Brand Network Exposures Product Safety Cybin Appoints Dr. Atul Mahableshwarkar M.D., as Senior Vice President, Clinical Development June 11, 2024 From Cybin Inc. Via Business Wire Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment June 05, 2024 FDA panel rejects MDMA therapy for PTSD, citing lack of evidence for benefits outweighing risks. Psychedelic stocks take a hit, with CYBN, MNMD, and ATAI down. FDA not bound by decision. Via Benzinga Exposures Product Safety InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Announces Participation at Interdisciplinary Conference on Psychedelic Research 2024 May 29, 2024 Via Investor Brand Network Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024 May 29, 2024 From Cybin Inc. Via Business Wire BioMedNewsBreaks — Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO Slated to Present at Upcoming Alliance Global Partners Healthcare Company Showcase May 14, 2024 Via Investor Brand Network Cybin to Participate in the Alliance Global Partners Healthcare Company Showcase May 14, 2024 From Cybin Inc. Via Business Wire Pot Company Gets License To Open Psilocybin Service Center, The Sacred Mushroom, In Oregon May 09, 2024 Via Benzinga Topics Cannabis Exposures Cannabis PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Issues Corporate Update, Eyes Runway for Upcoming Clinical Milestones May 06, 2024 Via Investor Brand Network Exposures Product Safety Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones May 06, 2024 From Cybin Inc. Via Business Wire PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Announces Participation at the 27th Annual Milken Institute Global Conference April 25, 2024 Via Investor Brand Network Exposures Product Safety Cybin to Participate at the 27th Annual Milken Institute Global Conference April 25, 2024 From Cybin Inc. Via Business Wire PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Research Published in “Journal of Medicinal Chemistry” April 18, 2024 Via Investor Brand Network Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry April 18, 2024 From Cybin Inc. Via Business Wire InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Receives Notice of Patent Grant for CYB003 Breakthrough MDD Therapy Program April 16, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder April 16, 2024 From Cybin Inc. Via Business Wire PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) to Present at Bloom Burton & Co. Healthcare Conference April 10, 2024 Via Investor Brand Network Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference April 10, 2024 From Cybin Inc. Via Business Wire Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More March 30, 2024 Via Benzinga 3 Penny Stocks That Could Be Multibaggers in the Making: March Edition March 26, 2024 Penny stocks are incredibly risky. However, if you can handle the heat, these ideas might be worth your while. Via InvestorPlace Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More March 20, 2024 Via Benzinga Topics Economy Exposures Interest Rates < Previous 1 2 3 4 5 6 7 8 9 ... 37 38 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.